CranioSense
Noninvasive brain pressure monitoring, anywhere it's needed
- Headquarters
- Bedford, Massachusetts
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- craniosense.com
- Total Funding
- $5.7M
- Last Round
- $5.5M GrantDec 2025
About
CranioSense is a clinical-stage medtech company developing IPASS, a noninvasive intracranial pressure monitoring device that measures ICP in seconds using a forehead patch and handheld sensors — no skull drilling required. The company targets traumatic brain injury, ICU, and emergency care settings where current invasive ICP methods are too risky to use broadly. CranioSense was awarded $5.5M in NIH and DoD federal grants in late 2024.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account